Embecta Corp

EMBCNASDAQ · USD
6.27USD0.00 (-2.80%)
10510

Embecta Corp (EMBC) Covered Calls

As of October 16, 2026, EMBC has 5 covered call opportunities in the coming three months. Return ranges from 20.4 to 61.9% until expiration. Annualized return ranges from 54.5 to 212.9%. The nearest expiration is November 20, 2026. Maximum potential profit is $388.

Read more

Running EMBC covered calls helps you generate consistent income from Embecta Corp's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Embecta Corp involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best EMBC covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if EMBC stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling EMBC covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Embecta Corp covered call is worth writing.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.

Income-focused investors, long-term EMBC holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling EMBC covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Embecta Corp covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryMedical Instruments & Supplies
  • SectorHealthcare
  • IV percentile28.57% Subdued
  • Market cap (M$)355
  • 52 weeks high-57.95%
  • 52 weeks low126.35%
  • Analyst recommendationHold
    3.20
  • Target price$4.00
    -36.20% below the current stock price
  • Dividend—
  • Payout ratio37.05%
  • Earnings date2026-11-24
  • P/E4.23
  • Future P/E3.56
  • EPS (ttm)1.48
  • EPS growth next 5 years-12.88%

As of October 16, 2026

2026-11-20357.5019.620.050.20128.0020.41212.90-0.80+0.208520.15
2026-12-18637.5019.620.250.45148.0023.60136.76-3.99+0.3310.20
2027-05-2121710.0059.490.150.70388.0061.88104.09-2.39+0.272240.55
2027-02-191267.5019.620.501.05173.0027.5979.93-7.97+0.451940.55
2027-05-212177.5019.620.801.15203.0032.3854.46-12.76+0.49410.35

As of October 16, 2026

Sell covered calls with the data behind you

Find the best EMBC covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial